Common use of Subsequent Equity Sales Clause in Contracts

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 8 contracts

Samples: Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Airborne Wireless Network)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 8 contracts

Samples: Securities Purchase Agreement (Creatd, Inc.), Securities Purchase Agreement (Motus GI Holdings, Inc.), Securities Purchase Agreement (Actelis Networks Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.), Securities Purchase Agreement (Rocketfuel Blockchain, Inc.), Securities Purchase Agreement (International Land Alliance Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (enVVeno Medical Corp), Securities Purchase Agreement (WeTrade Group Inc.), Securities Purchase Agreement (ASP Isotopes Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Oncocyte Corp), Securities Purchase Agreement (Arcadia Biosciences, Inc.), Securities Purchase Agreement (NextPlat Corp)

Subsequent Equity Sales. (a) From Except with respect to the issuances described on Schedule 4.13 hereto, from the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Ensysce Biosciences, Inc.), Securities Purchase Agreement (Isun, Inc.), Securities Purchase Agreement (Ensysce Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Vycor Medical Inc), Securities Purchase Agreement (Fibrocell Science, Inc.), Securities Purchase Agreement (Vu1 CORP)

Subsequent Equity Sales. (a) From the date hereof until sixty the date that is six (606) days hereaftermonths following the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 4 contracts

Samples: Securities Purchase Agreement (Vivos Therapeutics, Inc.), Securities Purchase Agreement (Iveda Solutions, Inc.), Securities Purchase Agreement (Dermata Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Safe-T Group Ltd.), Securities Purchase Agreement (BioLineRx Ltd.), Securities Purchase Agreement (BioLineRx Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.)

Subsequent Equity Sales. (a) From Except as provided in paragraph (c) below, from the date hereof until sixty (60) 120 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents pursuant to which a Person is entitled to acquire shares of Common Stock at an effective price per share that is less than $3.25.

Appears in 3 contracts

Samples: Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.)

Subsequent Equity Sales. (ai) From the date hereof until sixty (60) 180 days hereafterfollowing the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.. For the purposes hereof, “

Appears in 3 contracts

Samples: Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection with any employee compensation plan.

Appears in 3 contracts

Samples: Securities Purchase Agreement (T2 Biosystems, Inc.), Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.), Securities Purchase Agreement (Lipella Pharmaceuticals Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Healthcare Triangle, Inc.), Securities Purchase Agreement (MMEX Resources Corp), Securities Purchase Agreement (Clearone Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 3 contracts

Samples: Securities Purchase Agreement (BigBear.ai Holdings, Inc.), Securities Purchase Agreement (Creative Medical Technology Holdings, Inc.), Securities Purchase Agreement (NewAge, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Citius Pharmaceuticals, Inc.), Securities Purchase Agreement (Caladrius Biosciences, Inc.), Securities Purchase Agreement (Phio Pharmaceuticals Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Movano Inc.), Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Cancer Genetics, Inc)

Subsequent Equity Sales. (ai) From the date hereof until the date that is sixty (60) days hereafterfollowing the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (ImmunoCellular Therapeutics, Ltd.), Underwriting Agreement (Immune Pharmaceuticals Inc), Underwriting Agreement (Immune Pharmaceuticals Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior written approval of the Preferred Director (as defined in Section 4.18).

Appears in 3 contracts

Samples: Securities Purchase Agreement (MICT, Inc.), Securities Purchase Agreement (MICT, Inc.), Form of Securities Purchase Agreement (BNN Technology PLC)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred eighty (60180) days hereafterfollowing the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus or (iii) amend, modify or waiver the terms of any securities outstanding on the date hereof.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date (such applicable period, the “Restricted Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents(ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty twelve (6012) days hereaftermonths, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.), Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Intec Parent Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 120 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents; provided, however, if such issuance is in connection with an up-listing to a “national securities exchange” as defined in Rule 600(b) of Regulation NMS, such issuance may occur at any time after the Reverse Stock Split Date.

Appears in 3 contracts

Samples: Share Purchase Agreement (Edison Nation, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without Majority Approval.

Appears in 2 contracts

Samples: Securities Purchase Agreement (VerifyMe, Inc.), Securities Purchase Agreement (VerifyMe, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Peraso Inc.), Securities Purchase Agreement (Peraso Inc.)

Subsequent Equity Sales. (a) From Without the prior consent of the Placement Agents or the Purchasers representing a majority of the aggregate Subscription Amount in this offering, from the date hereof until sixty (60) 60 days hereafterafter the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for any at-the-market offerings or equity lines of credit or in connection with any strategic collaboration.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Better Therapeutics, Inc.), Securities Purchase Agreement (Better Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing, neither the Company nor any Subsidiary subsidiary shall (i) issue, enter into any agreement to issue issue, or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents, or (ii) file or amend any registration statement or prospectus, other than as necessary to maintain the registration of the Securities governed by this Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (SuperCom LTD), Securities Purchase Agreement (SuperCom LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Xenetic Biosciences, Inc.), Underwriting Agreement (Xenetic Biosciences, Inc.)

Subsequent Equity Sales. (a) From the Closing Date until the date hereof until sixty that is thirty (6030) trading days hereafterthereafter, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of (i) Common Stock Shares or Common Stock EquivalentsShare Equivalents or (ii) convertible debt securities (and underlying shares upon the conversion thereof) to any of the officers (or their affiliated entities) or directors of the Company, without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Cesca Therapeutics Inc.), Underwriting Agreement (Intellipharmaceutics International Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Rosetta Genomics Ltd.), Securities Purchase Agreement (Rosetta Genomics Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Actelis Networks Inc), Securities Purchase Agreement (Odyssey Health, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as (i) contemplated pursuant to the Registration Rights Agreement or (ii) necessary to maintain the effectiveness of existing registration statements which are effective as of the Effective Date.

Appears in 2 contracts

Samples: Securities Purchase Agreement (VerifyMe, Inc.), Securities Purchase Agreement (GeoVax Labs, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 2 contracts

Samples: Securities Purchase Agreement (BlackSky Technology Inc.), Securities Purchase Agreement (Brooklyn ImmunoTherapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 180 days hereafterfollowing the Execution Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents.

Appears in 2 contracts

Samples: Underwriting Agreement (CardieX LTD), Underwriting Agreement (Cellect Biotechnology Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock EquivalentsShare Equivalents without the prior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Castor Maritime Inc.), Underwriting Agreement (Castor Maritime Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or to register for resale the shares underlying the Company’s outstanding warrants.

Appears in 2 contracts

Samples: Securities Purchase Agreement (SHF Holdings, Inc.), Securities Purchase Agreement (Northern Lights Acquisition Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the written approval of the Purchasers of 50.1% or greater of the Securities issued hereunder, based on initial Subscription Amounts hereunder.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Inspyr Therapeutics, Inc.), Securities Purchase Agreement (Inspyr Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the anniversary of the date of this Agreement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Grom Social Enterprises, Inc.), Securities Purchase Agreement (Grom Social Enterprises, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Arcimoto Inc), Securities Purchase Agreement (Silo Pharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or file any registration statement or supplement or amendment thereto (other than in connection with this offering).

Appears in 2 contracts

Samples: Underwriting Agreement (Cyclo Therapeutics, Inc.), Cyclo Therapeutics, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafter90 Trading Days following the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, this Section 4.19 shall not apply in respect of (x) an Exempt Issuance or (y) any filing by the Company of a registration statement, prospectus or other document with the Commission or related announcement pursuant to the Investors’ Rights Agreement or the Registration Rights Agreement.

Appears in 2 contracts

Samples: Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty 30 days after the Effective Date (60) days hereafterthe “Lock-Up Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.), Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterthe 180th day following the IPO Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Smart for Life, Inc.), Securities Purchase Agreement (Bluejay Diagnostics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Innovative Payment Solutions, Inc.), Securities Purchase Agreement (Coretec Group Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the date on which there is a currently effective registration statement covering all of the Conversion Shares that are Registrable Securities (as defined in the Registration Rights Agreement), neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Accurexa Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents without the express prior written consent of a majority in interest of the Purchasers, not to be unreasonably withheld or delayed.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cortex Pharmaceuticals Inc/De/)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Form of Securities Purchase Agreement (ReWalk Robotics Ltd.)

Subsequent Equity Sales. (a) From Except with respect to the issuances described on Schedule 4.13 hereto, from the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (CENNTRO ELECTRIC GROUP LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty the earlier of (60i) one-hundred eighty (180) days hereafterafter the Closing Date and (ii) 30 days from the Effectiveness Date (as defined in the Registration Rights Agreement) of the Initial Registration Statement (as defined in the Registration Rights Agreement), neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ari Network Services Inc /Wi)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Closing, neither the Company nor any Subsidiary subsidiary shall (i) issue, enter into any agreement to issue issue, or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or (ii) file or amend any registration statement or prospectus, other than as necessary to maintain the registration of the Securities governed by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Momentus Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Shareholder Approval Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or as contemplated pursuant to Section 4.17 herein.

Appears in 1 contract

Samples: Securities Purchase Agreement (Creative Medical Technology Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of (x) an Exempt Issuance or (y) any filing by the Company of a registration statement, prospectus or other document with the Commission or related announcement pursuant to the Investors’ Rights Agreement or the Registration Rights Agreement.

Appears in 1 contract

Samples: Underwriting Agreement (Ceres, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement and other than any registration statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Molekule Group, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Clearone Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock EquivalentsShares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, except as required to be filed pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (BriaCell Therapeutics Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 120 days hereafterafter the date hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (Fangdd Network Group Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 1 contract

Samples: Securities Purchase Agreement (Staffing 360 Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty 60 (60sixty) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (Citius Pharmaceuticals, Inc.)

Subsequent Equity Sales. (a) From the date hereof until For sixty (60) days hereafterfollowing the date hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus Supplement or the filing of a registration statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Indaptus Therapeutics, Inc.)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, other than a transaction for the sale of Company securities to one or more of the Purchasers that purchase a majority of the Preferred Stock sold pursuant to this Agreement or (ii) file any registration statement or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (Healthier Choices Management Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterthe Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Creek Road Miners, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than (A) as contemplated pursuant to the Registration Rights Agreement or (B) the filing of a registration statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Apexigen, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterfollowing the Effective Date pursuant to which all Shares and Warrant Shares are registered for resale, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Renovare Environmental, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterfollowing the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Bright Green Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date (the “Lock-Up Expiration Date”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (SenesTech, Inc.)

Subsequent Equity Sales. (a) From the date hereof until [sixty (60) days hereafterdays] after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock EquivalentsOrdinary Share Equivalents (each, a “Subsequent Placement”).

Appears in 1 contract

Samples: Form Securities Purchase Agreement (WiMi Hologram Cloud Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred twenty (60120) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement with the Commission related to the offering of any shares of Common Stock or any Common Stock equivalents.

Appears in 1 contract

Samples: Underwriting Agreement (Beam Global)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Preferred Investment Option Shares and the Private Placement and the Warrant Amendment.

Appears in 1 contract

Samples: Securities Purchase Agreement (Enveric Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafter, after the Closing Date neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, without the prior approval of either not less than 50.1% of the holders in interest of the Shares based on the initial Subscription Amounts hereunder, or the Placement Agent, which approval shall not be unreasonably withheld or delayed.

Appears in 1 contract

Samples: Securities Purchase Agreement (authID Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty fourteen (6014) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement (including the filing of the Universal Shelf (as defined therein) contemplated thereby).

Appears in 1 contract

Samples: Securities Purchase Agreement (Exela Technologies, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or a Registration Statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Salarius Pharmaceuticals, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or file any registration statement or any amendment or supplement thereto relating to the offering of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company (other than a registration statement on Form S-8), in each case other than as contemplated by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Intrusion Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement (other than a Registration Statement on Form S-8) or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Adomani, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, or announce the issuance foregoing or proposed issuance of any shares of capital stock of the Company or Common Stock Equivalents; or (ii) file or caused to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company or Common Stock Equivalents.

Appears in 1 contract

Samples: Engagement Agreement (Telemynd, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) calendar days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or file any registration statement under the Securities Act other than a resale registration statement relating to the Warrant Shares.

Appears in 1 contract

Samples: Securities Purchase Agreement (Datasea Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, other than as otherwise permitted herein and the filing of any “shelf registration statement” on Form S-3.

Appears in 1 contract

Samples: Securities Purchase Agreement (Serve Robotics Inc. /DE/)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, and other than a prospectus supplement to be filed in connection with the Registered Direct.

Appears in 1 contract

Samples: Securities Purchase Agreement (Avinger Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than as contemplated pursuant to the Registration Rights Agreement or filing a registration statement on Form S-8 in connection with any employee benefit plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (Toughbuilt Industries, Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto. Notwithstanding the foregoing, this Section 4.12(a) may be waived in writing with the prior written consent of a majority in interest of the Purchasers hereunder (based on Subscription Amounts hereunder).

Appears in 1 contract

Samples: Securities Purchase Agreement (Crown Electrokinetics Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (ASP Isotopes Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Shares Equivalents (each, a “Subsequent Placement”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Luokung Technology Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or (ii) or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus Supplement.

Appears in 1 contract

Samples: Securities Purchase Agreement (American Resources Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall not (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, other than the Prospectus.

Appears in 1 contract

Samples: Securities Purchase Agreement (Edible Garden AG Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 trading days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Alpine 4 Technologies Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Shareholder Approval Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or (ii) file any registration statement or amendment or supplement thereto, other than with respect to the Registration Statement or a registration statement on Form S-8, except for the Securities issued pursuant hereto or otherwise in connection with the Offering.

Appears in 1 contract

Samples: Securities Purchase Agreement (Glucotrack, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days hereaftermonths after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterafter June 12, 2009, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Adventrx Pharmaceuticals Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty 50 (60fifty) days hereafterafter the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto other than the Prospectus Supplement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Hancock Jaffe Laboratories, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock EquivalentsOrdinary Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (CYREN Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty fifty (6050) days hereafterafter the Closing Date, neither the Company nor any Subsidiary subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, or (ii) file any registration statement or prospectus, or any amendment or supplement thereto.

Appears in 1 contract

Samples: Securities Purchase Agreement (AzurRx BioPharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Common Warrant Shares and the Private Placement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Shares Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Top Image Systems LTD)

Subsequent Equity Sales. (a) From the date hereof until the date that is sixty (60) days hereafterafter the effective date of the Registration Statement, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (NeuroMetrix, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days hereafterTrading Days following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.13(a) shall not apply to a Permitted Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (Esports Entertainment Group, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, other than as otherwise permitted herein and the filing of any “shelf registration statement” on Form S-3.

Appears in 1 contract

Samples: Securities Purchase Agreement (Serve Robotics Inc. /DE/)

Subsequent Equity Sales. (a) From the date hereof until sixty forty five (6045) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for issuances of Common Stock priced at a price per share of Common Stock in excess of 110% of the Per Share Purchase Price.

Appears in 1 contract

Samples: Securities Purchase Agreement (AzurRx BioPharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement

Appears in 1 contract

Samples: Securities Purchase Agreement (Smart for Life, Inc.)

Subsequent Equity Sales. (a) From the date hereof (i) until sixty ninety (6090) days hereafterafter the Effective Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock EquivalentsEquivalents or (ii) until the Effective Date, file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement or a post-effective amendment to an existing registration statement necessary to continue such registration without lapse.

Appears in 1 contract

Samples: Securities Purchase Agreement (Stryve Foods, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!